Harvard Researchers Detail CBD Nano-Micelle Protocol Designed to Improve Solubility and …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDSafetyDosingPolicyPainAnxiety Why This Matters Clinicians prescribing CBD or considering it for patients need…
Cannabis Formula Granted "Breakthrough Therapy Designation" by FDA for Pain Treatment
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainPolicyResearchSafetyAnxietyMental HealthDosing Why This Matters This FDA breakthrough therapy designation accelerates…
France submits decree on the reimbursement of medical cannabis to the Council of State
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyPainNeurologyMental HealthSafetyResearchAnxiety Why This Matters France’s reimbursement decision removes a…
Cannabis Terpenes Enhance THC’s Activation of Cannabinoid Receptors, Study Finds
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCNeurologySafetyDosingMental HealthAnxiety Why This Matters Clinicians need to understand that cannabis…
In the Mix: 9 More Articles — July 06, 2026
9 cannabis articles clinical relevance scores fell below the CED threshold in the last 24 hours. This summary includes key points and source links for each article. Stay informed on the latest cannabis research updates.
DEA Moves to Schedule Four Emerging Synthetic Opioids
The Brorphine Schedule I process is moving forward as DEA targets four emerging synthetic opioids for temporary federal control. The drugs are appearing in illicit drug seizures and toxicology testing, including fatal cases involving cychlorphine. The…
HLB Life Science Selected for Fifth National Minor Cannabinoid Project
HLB Life Science has been selected for a fifth national project focused on minor cannabinoid drug development. This initiative highlights growing research into cannabinoid pharmaceuticals beyond THC and CBD. The project signals increasing institutional…
HLB Life Science R&D Launches Minor Cannabinoid Drug Development in Fifth State Project
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchHempIndustryPolicyCBDTHCNeurology Why This Matters Clinicians need to understand that minor cannabinoid drug…
Bhumjaithai pushes cannabis control bill
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustryHempCBDTHCMental Health Clinical Summary # Clinical Summary The Thai Bhumjaithai party is…
Millions Have Fatty Liver Disease. Scientists Say These 2 Cannabis Compounds May Help
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchCBDHempSafetyAgingMental HealthAnxiety Why This Matters Clinicians treating patients with fatty liver disease…